TickerFacts.

A business in context

SLS research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-09-07 · 8010 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 8-K · Current report

    Report date 2026-08-11 · 0001390478-26-000013 · Items 2.02,9.01

  2. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001390478-26-000012

  3. 8-K · Current report

    Report date 2026-07-24 · 0001104659-26-087110 · Items 2.02,8.01,9.01

  4. 8-K · Current report

    Report date 2026-06-24 · 0001104659-26-077556 · Items 5.02,9.01

  5. 8-K · Current report

    Report date 2026-06-16 · 0001104659-26-075775 · Items 5.07

  6. 4 · Ownership change

    Report date 2026-06-16 · 0001104659-26-075773

  7. 8-K · Current report

    Report date 2026-06-02 · 0001104659-26-069251 · Items 8.01,9.01

  8. 8-K · Current report

    Report date 2026-05-12 · 0001390478-26-000009 · Items 2.02,9.01

  9. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001390478-26-000008

  10. DEF 14A · Proxy statement

    Report date 2026-06-16 · 0001104659-26-047693

  11. 8-K · Current report

    Report date 2026-03-19 · 0001390478-26-000004 · Items 2.02,9.01

  12. 10-K · Annual report

    Report date 2025-12-31 · 0001390478-26-000003

  13. 8-K · Current report

    Report date 2026-03-11 · 0001104659-26-026384 · Items 8.01,9.01

  14. 4 · Ownership change

    Report date 2026-01-07 · 0001104659-26-002515

  15. 4 · Ownership change

    Report date 2026-01-07 · 0001104659-26-002511

  16. 4 · Ownership change

    Report date 2026-01-07 · 0001104659-26-002509

  17. 4 · Ownership change

    Report date 2026-01-07 · 0001104659-26-002506

  18. 4 · Ownership change

    Report date 2026-01-07 · 0001104659-26-002502

  19. 4 · Ownership change

    Report date 2026-01-07 · 0001104659-26-002499

  20. 4 · Ownership change

    Report date 2026-01-07 · 0001104659-26-002491

  21. 8-K · Current report

    Report date 2026-01-07 · 0001104659-26-001957 · Items 2.02,8.01,9.01

  22. 8-K · Current report

    Report date 2025-11-12 · 0001390478-25-000021 · Items 2.02,9.01

  23. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001390478-25-000020

  24. 8-K · Current report

    Report date 2025-10-24 · 0001104659-25-102345 · Items 1.01,8.01,9.01

  25. 8-K · Current report

    Report date 2025-10-01 · 0001104659-25-096643 · Items 1.01,9.01

  26. 8-K · Current report

    Report date 2025-09-10 · 0001104659-25-089272 · Items 1.01,3.02,8.01,9.01

  27. 8-K · Current report

    Report date 2025-08-12 · 0001390478-25-000017 · Items 2.02,9.01

  28. 10-Q · Quarterly report

    Report date 2025-06-30 · 0001390478-25-000016

  29. 8-K · Current report

    Report date 2025-06-17 · 0001104659-25-060704 · Items 5.07

  30. 8-K · Current report

    Report date 2025-06-03 · 0001104659-25-057308 · Items 4.01,9.01

  31. 8-K · Current report

    Report date 2025-05-13 · 0001390478-25-000009 · Items 2.02,9.01

  32. 10-Q · Quarterly report

    Report date 2025-03-31 · 0001390478-25-000008

  33. DEF 14A · Proxy statement

    Report date 2025-06-17 · 0001104659-25-038039

  34. 8-K · Current report

    Report date 2025-03-20 · 0001390478-25-000004 · Items 2.02,9.01

  35. 10-K · Annual report

    Report date 2024-12-31 · 0001390478-25-000003

  36. 8-K · Current report

    Report date 2025-01-28 · 0001104659-25-007049 · Items 1.01,8.01,9.01

  37. 8-K · Current report

    Report date 2025-01-23 · 0001104659-25-005648 · Items 7.01,9.01

  38. 8-K · Current report

    Report date 2025-01-10 · 0001104659-25-004107 · Items 5.02

  39. 8-K · Current report

    Report date 2024-12-10 · 0001104659-24-127231 · Items 7.01,9.01

  40. 8-K · Current report

    Report date 2024-11-13 · 0001390478-24-000022 · Items 2.02,9.01

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-09-07 · 2026 Q2: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 0 transaction rows0SGrant / award: 1 transaction rows1AExercise / conversion: 0 transaction rows0MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

1 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-06-16
2026-06-18
Stergiou Angelos M.A · Grant / award
Acquired
Common Stock1065000.00.0

Identity & relationships

Wikidata structured data · retrieved 2026-09-07 · 1611 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001390478SELLAS Life Sciences Group, Inc.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-09-07 · 1177 checked identities; 0 unavailable records

Search names and former names

View Wikidata identity and references ↗

  • Galena Biopharma · alias · wikidata
  • Galena Biopharma (United States) · alias · wikidata
  • RXi Pharmaceuticals · alias · wikidata
  • GALENA BIOPHARMA, INC. · former SEC name · 2011-09-26 to 2017-12-15
  • Galena Biopharma, Inc. · former SEC name · 2011-09-26 to 2017-12-15
  • RXI PHARMACEUTICALS CORP · former SEC name · 2007-02-07 to 2011-09-21
Explore headquarters map ↗

Revenue in constant purchasing power

USD revenue expressed in 2026-07 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2023-12-31$0$0
2022-12-31$1.00M$1.14M
2021-12-31$7.60M$9.36M
2020-12-31$1.90M$2.45M
2019-12-31$0$0

Bureau of Labor Statistics · retrieved 2026-09-07 · 9 selected series; gaps remain missing

Explore the CPI history ↗